Teva Pharmaceutical’s $2.1 Billion Bond Offering

Baker McKenzie and Herzog, Fox & Neeman advised the syndicate of 14 initial purchasers on the deal. The offering consisted of USD 2.1 billion (equivalent) dual-tranche…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Paolo Bossi

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here